首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药临床试验中阳性对照药选择的新思路
引用本文:向楠,邓阿黎,李晓东,周亚娜.中药临床试验中阳性对照药选择的新思路[J].中国临床药理学与治疗学,2007,12(12):1395-1397.
作者姓名:向楠  邓阿黎  李晓东  周亚娜
作者单位:湖北省中医院国家药物临床试验机构,武汉,430061,湖北
摘    要:中药新药临床试验中,由于中医药诊疗体系的自身特点及特殊性,阳性对照药的选择常存在一些问题,严重影响试验药物的有效性评价。"复合对照"这一思路的提出,为今后的中药新药临床试验阳性对照药的选择提供了选择面很广的新方法,在探索中药有效性评价方面具有现实意义。

关 键 词:中药新药  临床试验  阳性对照药  选择  复合对照
文章编号:1009-2501(2007)12-1395-03
收稿时间:2007-08-09
修稿时间:2007-09-08

A new idea of the positive control medicine in the clinical trial of traditional Chinese medicine
XIANG Nan,DENG A-li,LI Xiao-dong,ZHOU Ya-na.A new idea of the positive control medicine in the clinical trial of traditional Chinese medicine[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2007,12(12):1395-1397.
Authors:XIANG Nan  DENG A-li  LI Xiao-dong  ZHOU Ya-na
Abstract:In the clinical trial of new traditional Chi- nese medicine,because of the special characteristics and particularity in the diagnosis and treatment system of TCM,the choice of the positive control medicine always face some problems.Which affects tire validity of clinical drug evaluation seriously.We present a new concept of"composite control".The new concept provides new ways,which is widely used in the choice of the positive control medicine in the clinical trial of TCM.It has real- istic significance to research the validity of clinical drug evaluation.
Keywords:new traditional Chinese drug  clinical trial  positive control medicine  choice  composite control
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号